UPDATE 1-BioCryst expects to begin Ebola study in weeks

Aug 29 (Reuters) - BioCryst Pharmaceuticals Inc said it expects to initiate a study within weeks to test its antiviral in primates for use against Ebola infections

from Reuters: Hot Stocks http://ift.tt/1sOX3ib